The results of this landmark study should be welcomed news to cancer patients across the world suffering from the debilitating effects of painful vertebral compression fractures,” said Dr. James Berenson, the study’s first author and Medical and Scientific Director of the Institute for Myeloma and Bone Cancer Research in Los Angeles, CA. “It is documented that nearly one-fourth (24 percent) of patients with multiple myeloma, 14 percent with breast cancer, 8 percent with lung cancer and 6 percent with prostate cancer suffer painful vertebral compression fractures. With the results of this new randomized study, there is now clinical evidence of a treatment option for spinal fractures in cancer patients that can provide excellent relief of pain and improved quality of life.”
Ruxolitinib Is Under Investigation as JAK Inhibition Strategy for Multiple Myeloma
CancerNetwork® spoke with James R. Berenson, MD, founder, medical and scientific director, and president and chief...